## Abstract Children with malignancy are immunosup‐pressed and susceptible to serious infections with herpesviruses. The majority of children on chemotherapy for malignancy are seropositive for human herpesvirus‐6 (HHV‐6), and although HHV‐6 has been demonstrated to be a pathogen in severely immuno
Serological response of paediatric oncology patients to human herpesvirus-6
✍ Scribed by E. G. Hermione Lyall
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 787 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The serological response of paediatric oncology patients to human herpesvirus‐6 (HHV‐6) was investigated at presentation and during treatment. Sera from 66 patients presenting with malignancy and 66 controls were examined for anti‐HHV‐6 IgG by indirect immunofluorescence test (IFA) and enzyme linked immunosorbent assay (ELISA), and for anti‐HHV‐6 IgM by IFA. Serial samples from 45 children on chemotherapy were examined for anti‐HHV‐6 IgG by ELISA and sera from selected patients on chemotherapy were examined for IgM by IFA. The response of these patients to four other herpesviruses was also investigated.
Ninety percent of presenting patients and controls were IgG positive for HHV‐6 by IFA and ELISA. Anti‐HHV‐6 IgG as measured by the HHV‐6 ELISA index declined overtime in patients on chemotherapy. Two presenting controls and one leukaemic child with a primary cytomegalo‐virus seroconversion were anti‐HHV‐6 IgM positive. In the patient group seropositivity to herpesviruses (types 1–6) increased with age, the mean age of those with IgG to HHV‐6 alone was 3.7 years compared to 6.8 years for those with antibodies to all five viruses.
At the time of presentation paediatric oncology patients have a similar serological response to HHV‐6 as age‐matched controls and this IgG response wanes with treatment. Whether this is significant in terms of viral pathogenicity is not known and will require investigation of viral activity in these patients. © 1994 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Fifty‐three (96%) of 55 patients with coronary artery stenosis were positive for serum anti‐HHV‐6 IgG, and 50 (91%) of these patients had anti‐HHV‐7 IgG. The number of cases sero‐positive for HHV‐6 and ‐7 in the 54 age matched control volunteers was 52 (96%) and 53 (98%), respectively.
## Abstract Like other herpesviruses, human herpesvirus 6 (HHV‐6) can reactivate in immunocompromised patients. A case is described of an HIV‐1‐infected patient who developed bilateral retrobulbar optic neuritis associated with HHV‐6 infection. A 59‐year‐old woman, infected with HIV for 18 years, i
Diagnosis of significant infections by human herpesvirus 6 (HHV6) and 7 (HHV7) in transplant patients has proved difficult because both viruses are ubiquitous and can cause persistent infections in their hosts. The significance of viral DNA detected in peripheral blood leukocytes (PBLs; DNAemia) by
## Abstract Sera from 50 orthotopic liver transplant recipients were examined for antibodies to human herpesvirus 6 (HHV‐6) and Cytomegalovirus (CMV), and the findings correlated with the clinical condition of the patients. Both primary and secondary HHV‐6 infections were detected sero‐logically fo